Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Nov-Dec;45(6):1209-1215.
doi: 10.1590/S1677-5538.IBJU.2019.0121.

Which of available selective serotonin reuptake inhibitors (SSRIs) is more effective in treatment of premature ejaculation? A randomized clinical trial

Soheila Siroosbakht  1 , Sadra Rezakhaniha  2 , Bijan Rezakhaniha  3
Affiliations
Randomized Controlled Trial

Which of available selective serotonin reuptake inhibitors (SSRIs) is more effective in treatment of premature ejaculation? A randomized clinical trial

Soheila Siroosbakht et al. Int Braz J Urol. 2019 Nov-Dec.

Abstract

Purpose: To compare the efficacy and safety of available selective serotonin reuptake inhibi-tors (SSRIs) in order to find the most effective drug with the least number of side effects in treatment of premature ejaculation (PE).

Materials and methods: This study was a randomized clinical trial. Four hundred and eighty pati-ents with PE in the 4 groups referred to Imam Reza hospital Tehran, Iran from July 2018 to Fe-bruary 2019 were enrolled in the study. The patients received sertraline 50mg, fluoxetine 20mg, paroxetine 20mg and citalopram 20mg, every 12 hours daily. The intravaginal ejaculatory laten-cy time (IELT) before treatment, fourth and eighth weeks after treatment was recorded by the patient's wife with a stopwatch.

Results: Mean IELT before, 4 and 8 weeks after treatment in four groups were: sertraline 69.4±54.3, 353.5±190.4, 376.3±143.5; fluoxetine 75.5±64.3, 255.4±168.2, 314.8±190.4; paroxeti-ne 71.5±69.1, 320.7±198.3, 379.9±154.3; citalopram 90.39±79.3, 279.9±192.1, 282.5±171.1 seconds, respectively. The ejaculation time significantly increased in all groups (p <0.05), but there was no significant difference between the groups (P=0.75). Also, there was no significant difference in drugs side effects between groups (p >0.05). The most common side effects were drowsiness and dyspepsia, which were not severe enough to cause discontinuation of the drug.

Conclusions: All available SSRIs were effective and usually had no serious complications. In patients who did not respond to any of these drugs, other SSRI drugs could be used as a salvage therapy.

Keywords: Citalopram; Fluoxetine; Premature Ejaculation.

PubMed Disclaimer

Conflict of interest statement

None declared.

Similar articles

See all similar articles

Cited by

References

    1. Rezakhaniha B, Safarinezhad MR. A survey of prevalence of Sexual Disorders and risk Factors in Patients who Referred in Urology ward in 501 Hospital 2004-5. JAUMS, winter. 2007;4:1041–1045. Avaliable at. < https://www.sid.ir/en/journal/ViewPaper.aspx?id=90734>.
    2. 1. Rezakhaniha, B, Safarinezhad, MR. A survey of prevalence of Sexual Disorders and risk Factors in Patients who Referred in Urology ward in 501 Hospital 2004-5. JAUMS, winter 2007; 4: 1041-5. Avaliable at. < https://www.sid.ir/en/journal/ViewPaper.aspx?id=90734>
    1. Abdel-Hamid IA, Ali OI. Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment. World J Mens Health. 2018;36:22–40. - PMC - PubMed
    2. 2. Abdel-Hamid IA, Ali OI. Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment. World J Mens Health. 2018;36:22-40. - PMC - PubMed
    1. McMahon CG. Premature ejaculation. Indian J Urol. 2007;23:97–108. - PMC - PubMed
    2. 3. McMahon CG. Premature ejaculation. Indian J Urol. 2007;23:97-108. - PMC - PubMed
    1. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med. 2014;11:1423–1441. - PubMed
    2. 4. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med. 2014;11:1423-41. - PubMed
    1. McMahon CG, Porst H. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med. 2011;8:2707–2725. - PubMed
    2. 5. McMahon CG, Porst H. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med. 2011;8:2707-25. - PubMed

Publication types